Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis
about
Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.Benefits of an expanded use of plasma exchange for anti-neutrophil cytoplasmic antibody-associated vasculitis within a dedicated clinical service.Pulmonary renal syndrome in a patient with vasculitis: Case report and review of literature.Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.Treatment of ANCA-associated vasculitis.Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis--a 25-year perspective.Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?Therapy and prognosis of ANCA-associated vasculitis from the clinical nephrologist's perspective.Double Filtration Plasmapheresis in the Treatment of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis With Severe Renal Failure: A Preliminary Study of 15 Patients.Rituximab for treatment of severe renal disease in ANCA associated vasculitis.Plasmapheresis therapy in ANCA-associated vasculitides: A single-center retrospective analysis of renal outcome and mortality.Presence of Anti-Glomerular Basement Membrane Antibodies and Myeloperoxidase Anti-Neutrophilic Cytoplasmic Antibodies in a Case of Rapidly Progressive GlomerulonephritisGlomerular disease: ANCA-associated GN--to PLEX or not to PLEX?Crescentic glomerulonephritis with dual positive anti-GBM and C-ANCA/PR3 antibodiesHistopathological Classification-A Prognostic Tool for Rapidly Progressive Glomerulonephritis
P2860
Q34873853-4BB61409-301B-4222-A6FE-F4EF0C7155BDQ35559034-59F4C47C-64A1-4C7E-A72B-253C32944DF0Q35836369-17C4E791-ECF8-48C1-A2C1-893D2A5C842DQ36553000-95A3D48C-C834-4E41-8F61-4675B751AF64Q37093451-2EE78F81-B60F-438E-81EF-4BFE9B4F773EQ38159916-1E9C1E3A-B81F-4DE3-A4C3-F7BBBC271904Q38377281-28B5CC23-8E99-42AB-BD25-36FE65689D3AQ38543360-453D1331-BE1B-4139-970D-63A81A8B5B8AQ38965278-D614EDDA-8DC7-424B-BAEC-564DDA31EDE1Q40765633-467BE7AE-E380-4DB3-8C31-3B3636B7DA9CQ40927033-FA2EFE58-DCD2-4948-BA6D-5B174D34AE61Q41099072-76847C1B-6F49-4F13-AADA-65D16A6704D4Q42425372-21D968CA-19C4-4096-A585-559BF74E9EE8Q44119588-3E60DAB1-156F-415C-B8C6-6216572215DFQ56881411-44DCF044-4C7D-4689-940D-5237CB42D3A9Q57825808-FEAA673C-F7CE-4A64-A810-6CB3F8E17EAC
P2860
Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intravenous cyclophosphamide a ...... ent ANCA-associated vasculitis
@ast
Intravenous cyclophosphamide a ...... ent ANCA-associated vasculitis
@en
type
label
Intravenous cyclophosphamide a ...... ent ANCA-associated vasculitis
@ast
Intravenous cyclophosphamide a ...... ent ANCA-associated vasculitis
@en
prefLabel
Intravenous cyclophosphamide a ...... ent ANCA-associated vasculitis
@ast
Intravenous cyclophosphamide a ...... ent ANCA-associated vasculitis
@en
P2093
P2860
P356
P1476
Intravenous cyclophosphamide a ...... ent ANCA-associated vasculitis
@en
P2093
Alan D Salama
Alina Casian
Charles D Pusey
Dimitrios Chanouzas
European Vasculitis Study (EUVAS) investigators
Lorraine Harper
Mark A Little
Michael Walsh
Ruth J Pepper
Ruth Tarzi
P2860
P304
P356
10.2215/CJN.03680412
P577
2012-11-15T00:00:00Z